Flexion Therapeutics Inc

NASDAQ:FLXN   12:16:53 PM EDT
13.50
+0.08 (+0.60%)
Earnings Announcements

Flexion Therapeutics Reports Q3 Sales Of $23.6 Mln

Published: 10/13/2020 11:36 GMT
Flexion Therapeutics Inc (FLXN) - Q3 Sales $23.6 Million Versus Refinitiv Ibes Estimate of $20.5 Million.
Revenue is expected to be $20.43 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $25.95 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.